Bromomethyl 3-methoxyphenyl ketone → Azemiglitazone

HRID 1428964Notes

Reaction equation

HRID 1428964 reaction equation
[OH:1][C:2]1[CH:15]=[CH:14][C:5]([CH2:6][CH:7]2[S:11][C:10](=[O:12])[NH:9][C:8]2=[O:13])=[CH:4][CH:3]=1.CC(C)([O-])C.[K+].Br[CH2:23][C:24]([C:26]1[CH:31]=[CH:30][CH:29]=[C:28]([O:32][CH3:33])[CH:27]=1)=[O:25]>CS(C)=O>[CH3:33][O:32][C:28]1[CH:27]=[C:26]([C:24](=[O:25])[CH2:23][O:1][C:2]2[CH:15]=[CH:14][C:5]([CH2:6][CH:7]3[S:11][C:10](=[O:12])[NH:9][C:8]3=[O:13])=[CH:4][CH:3]=2)[CH:31]=[CH:30][CH:29]=1

Participants

5

Procedure

To a stirring solution of 5-(4-hydroxybenzyl)thiazolidine-2,4-dione (100 mg, 0.4 mmol) in DMSO (2 ml), potassium tert-butoxide (106 mg, 0.941 mmol) was added. Stirring continued at RT for about 1 hour. 2-Bromo-3′-methoxyacetophenone (100 mg, 0.5 mmol) was then added to the mixture. After 2 hours, LCMS showed that the reaction was complete. The reaction mixture was partitioned between EtOAc and water, and the aqueous phase was extracted with EtOAc. Combined extracts were washed with brine, dried on (Na2SO4), filtered, and evaporated in vacuo. The residue was analyzed on a small RediSep column eluting with 0-10% acetone/DCM. Fractions containing the product were combined and evaporated in vacuo to afford 70 mg of 5-{4-[2-(3-methoxyphenyl)-2-oxoethoxy]benzyl}-1,3-thiazolidine-2,4-dione as a pale yellow solid.

Workup

  1. waitAfter 2 hours
  2. customThe reaction mixture was partitioned between EtOAc and water
  3. extractionthe aqueous phase was extracted with EtOAc
  4. washCombined extracts were washed with brine
  5. dry with materialdried on (Na2SO4)
  6. filtrationfiltered
  7. customevaporated in vacuo
  8. washeluting with 0-10% acetone/DCM
  9. additionFractions containing the product
  10. customevaporated in vacuo

Sources & evidence

ORD record
ord-7ec8260ffd40434a8463bbae252b50c0
Source dataset
uspto-grants-2015_01
Patent number
US08937182B2

Reaction notes

Loading…